In a clinical trial, it is verified that the inhibition of a protein allows to stop the progression of the Oncology Disease Researchers in the Research Group on cancer molecular therapy of the Hospital del Mar de Investigaciones Médicas (IMIM) Hospital del Mar have demonstrated the efficacy of a drug in patients with metastatic bladder cancer that did not respond to the usual treatment.
The study also has the participation of the Santa Creu and Sant Pau Hospital, the Parc Taulí de Sabadell University Hospital, the University Clinic of Navarra and the General Hospital General of Elche.
Regió 7
https://www.recercasantpau.cat/wp-content/uploads/2019/10/Recerca_Regio7-31082019-1.pdf
